Y-strut is an implantable medical device designed to prevent hip fracture that is now ready for commercial release in Europe. The device is designed to be implanted using a minimally invasive procedure by orthopaedic surgeons or interventional radiologists.
It is intended to be used in two clinical indications. In oncology, it is for percutaneous internal fixation for impending pathological fracture of the proximal femur. In this indication, it is an act of last resort (ultima ratio). In traumatology, the device is for contralateral percutaneous internal fixation of proximal femur, in patients with low energy pertrochanteric fracture on the first side.
According to a press release from Hyprevention, 14 patients have successfully benefited from Y-strut technology in clinical trials jointly conducted at the University Hospital of Bordeaux, France and the Gustave Roussy Institute in Paris, France and at the University Hospital Brugmann in Brussels, Belgium.
